menu
    • menu

    Company profile for Certara

    NEW Drugs in Dev: 1
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Advancing the Efficiency of Drug Development through Innovation Developing new drug therapies and providing them to patients is a complex process. At Certara, we have brought together a unique set of disciplines and technologies to address those underlying factors. We are the industry leader in applying a quantitative decision-making framework across the drug development life cycle, bridging from safety and efficacy to effect...
    Advancing the Efficiency of Drug Development through Innovation Developing new drug therapies and providing them to patients is a complex process. At Certara, we have brought together a unique set of disciplines and technologies to address those underlying factors. We are the industry leader in applying a quantitative decision-making framework across the drug development life cycle, bridging from safety and efficacy to effectiveness. Certara services and software span the drug development lifecycle—from discovery to patient access.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CertaraUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Overlook Center, Suite 101, Princeton, NJ 08540
    Telephone
    Telephone
    609.716.7900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    https://www.linkedin.com/company/certara
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/certara

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Certara Simcyp Replaces Ten Trials for CML Drug Asciminib
    Certara Simcyp Replaces Ten Trials for CML Drug Asciminib

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248265/0/en/Certara-Simcyp-Simulator-Results-Replace-Ten-Human-Trials-for-Chronic-Myeloid-Leukemia-CML-Therapy-asciminib.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Certara To Participate In Upcoming Investor Conferences
    Certara To Participate In Upcoming Investor Conferences

    27 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/27/3246504/0/en/Certara-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    27 Feb 2026
    Share Share
    Certara To Release Q4 And Full Year 2025 Financial Results
    Certara To Release Q4 And Full Year 2025 Financial Results

    29 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/29/3228581/0/en/Certara-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-26th-2025.html

    GLOBENEWSWIRE
    29 Jan 2026
    Share Share
    Certara Appoints Jon Resnick As Chief Executive Officer
    Certara Appoints Jon Resnick As Chief Executive Officer

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203731/0/en/Certara-Appoints-Jon-Resnick-as-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    Certara Reports Third Quarter 2025 Financial Results
    Certara Reports Third Quarter 2025 Financial Results

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183177/0/en/Certara-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Certara Automates Scientific Workflows with Phoenix Cloud
    Certara Automates Scientific Workflows with Phoenix Cloud

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180251/0/en/Certara-Automates-Scientific-Workflows-with-Phoenix-Cloud.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search